Hydrochloric Acid

Hydrochloric Acid

SCHEMBL710942

CC1=C(C)C(C)(C)C([Zr])=C1C.Cl.Cl.Cl

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27553871 1.00 CTSD (0.33) CTSD
Hydrochloric Acid SCHEMBL149638 1.00 CTSD (0.33) CTSD
Methane SCHEMBL8847115 0.97 CTSD (0.32) CTSD
SCHEMBL812577 0.97 CTSD (0.35) CTSD
Fluoride SCHEMBL1131348 0.94 CTSD (0.33) CTSD
Bromide SCHEMBL1539586 0.94 CTSD (0.33) CTSD
Iodide SCHEMBL27948708 0.94 CTSD (0.33) CTSD
Fluoride SCHEMBL27948615 0.94 CTSD (0.33) CTSD
Methyl Alcohol SCHEMBL5277411 0.92 CTSD (0.32) CTSD
Chloromethane SCHEMBL8161132 0.92 CTSD (0.32) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 496 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024078525-A1 PHOSPHINE-PHENOL HALF-METALLOCENE COMPLEX, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国石油化工股份有限公司 2024-04-18 WO claimed
US-20180244812-A1 Spherical Supported Transition Metal Catalyst PETROCHINA COMPANY LIMITED (CN) 2018-08-30 US claimed
US-9556286-B2 Catalyst for olefin polymerization, method for its preparation and use thereof SCG CHEMICALS CO., LTD. (TH) 2017-01-31 US claimed
US-20160130371-A1 CATALYST FOR OLEFIN POLYMERIZATION, METHOD FOR ITS PREPARATION AND USE THEREOF SCG CHEMICALS CO., LTD. (TH) 2016-05-12 US claimed
EP-2816051-B1 Catalyst for olefin polymerization, method for its preparation and use thereof SCG CHEMICALS CO LTD (TH) 2015-11-04 EP claimed
EP-2816051-A1 Catalyst for olefin polymerization, method for its preparation and use thereof Scg Chemicals Co. Ltd. (TH) 2014-12-24 EP claimed
WO-2014202329-A1 CATALYST FOR OLEFIN POLYMERIZATION, METHOD FOR ITS PREPARATION AND USE THEREOF SCG CHEMICALS CO., LTD. (TH) 2014-12-24 WO claimed
US-7767771-B2 Chain growth reaction process INEOS EUROPE LIMITED (GB) 2010-08-03 US claimed
US-20080200709-A1 Chain growth reaction process BARCLAYS BANK PLC (GB) 2008-08-21 US claimed
US-7323524-B2 Tandem tetramerisation-polymerisation of olefins SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2008-01-29 US claimed
US-4935397-A COORDINATION CATALYST EXXON CHEMICAL PATENTS INC. (US) 1990-06-19 US claimed
WO-1990005151-A1 METHOD FOR PREPARING POLYETHYLENE WAX BY GAS PHASE POLYMERIZATION EXXON CHEMICAL PATENTS INC. (US) 1990-05-17 WO claimed
US-4925821-A SILICA GEL CATALYST SUPPORT EXXON CHEMICAL PATENTS INC. (US) 1990-05-15 US claimed
EP-0367503-A1 Method for utilizing triethylaluminum to prepare an alumoxane support for an active metallocene catalyst EXXON CHEMICAL PATENTS INC. (US) 1990-05-09 EP claimed
EP-0367597-A1 Method for preparing polyethylene wax by gas phase polymerization EXXON CHEMICAL PATENTS INC. (US) 1990-05-09 EP claimed
WO-1990003403-A1 A SUPPORTED METALLOCENE-ALUMOXANE CATLYST FOR HIGH PRESSURE POLYMERISATION OF OLEFINS AND A METHOD OF PREPARING AND USING THE SAME EXXON CHEMICAL PATENTS INC. (US) 1990-04-05 WO claimed
EP-0361866-A1 A supperted metallocene-allumoxane catalyst for high pressure polymerization of olefins and a method of preparing and using the same EXXON CHEMICAL PATENTS INC. (US) 1990-04-04 EP claimed
US-4914253-A USING A SUPPORTED GROUP 4 OR 5 METALLOCENE-ALUMOXANE CATALYST; MOLECULAR WEIGHT CONTROL WITH HYDROGEN EXXON CHEMICAL PATENTS INC. (US) 1990-04-03 US claimed
US-4912075-A Mixing silic gel with trialkyl aluminum and metallocene EXXON CHEMICAL PATENTS INC. (US) 1990-03-27 US claimed
EP-0323716-A1 Method for preparing a supported metallocene-alumoxane catalyst for gas phase polymerization EXXON CHEMICAL PATENTS INC. (US) 1989-07-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130371-A1 CATALYST FOR OLEFIN POLYMERIZATION, METHOD FOR ITS PREPARATION AND USE THEREOF AOC2, AOC3, AOX1 CTSD 1329/4885
US-20080200709-A1 Chain growth reaction process ALOX12, ADH1A, ADH1C CTSD 742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.